NZ . Appreciate your insights as always. This doesn't seem to align with the scheduled submission of Section 29 to Medsafe conditional approval request that LCT proposed for May / June 2019 assuming all well with trial completion. Do you believe that is a red herring? Or is that the rabbit out of the hat you are hoping Management can pull off. ? Thanks .
Ann: CEO Presentation to the 2018 Annual General Meeting, page-125
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $1.942K | 277.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 8049466 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 303460 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |